The vulnerable plaque: Current concepts and future perspectives on coronary morphology, composition and wall stress imaging

Revista Portuguesa de Cardiologia

Volumn 33, Issue 2, 2014, Pages 101-110

  Marques, João Silva ^a   Pinto, Fausto J ^a  

^a HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

Acute coronary syndromes; Atherosclerosis; Molecular imaging; Vulnerable plaque

Indexed keywords

APOPTOSIS; ARTERY WALL; ATHEROSCLEROSIS; CARDIAC IMAGING; CARDIOVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; INFLAMMATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; REVIEW; RUPTURE; SHEAR STRESS; SOCIOECONOMICS; THROMBOSIS; TISSUE CHARACTERIZATION; WALL STRESS; COMPLICATION; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; FORECASTING; PATHOLOGY; TRENDS;

APOPTOSIS; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; FORECASTING; HUMANS; INFLAMMATION; THROMBOSIS;

EID: 84898825036     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.repc.2013.07.017     Document Type: Short Survey

References (98)

1. Shah PK. Molecular mechanisms of plaque instability. Curr Opin Lipidol. 2007;18:492-9.
2. Gibbons RJ, Jones DW, Gardner TJ, et al. The American Heart Association's 2008 Statement of Principles for Healthcare Reform. Circulation. 2008;118:2209-18.
3. Stary HC. Composition and classification of human atherosclerotic lesions. Virchows Arch A Pathol Anat Histopathol. 1992;421:277-90.
4. Stary HC, Chandler AB, Glagov S, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1994;89:2462-78.
5. Libby PRidker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135-43.
6. Fuster V, Moreno PR, Fayad ZA, et al. Atherothrombosis and high-ris plaque: part I: evolving concepts. J Am Coll Cardiol. 2005;46:937-54.
7. Moreno PR, Purushothaman KR, Fuster V, et al. Intimo-medial interface damage and adventitial inflammation is increased beneath disrupted atherosclerosis in the aorta: implications for plaque vulnerability. Circulation. 2002;105: 2504-11.
8. Davies MJ, Woolf N, Rowles PM, et al. Morphology of the endothelium over atherosclerotic plaques in human coronary arteries. Br Heart J. 1988;60:459-64.
9. Faggiotto A, Ross R, Harker L. Studies of hypercholesterolemia in the nonhuman primate I. Changes that lead to fatty streak formation. Arteriosclerosis. 1984;4:323-40.
10. Gerrity RG. The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol. 1981;103:181-90.
11. Jonasson L, Holm J, Skalli O, et al. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis. 1986;6:131-8.
12. Kovanen PT, Kaartinen M, Paavonen T. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or ruptur in myocardial infarction. Circulation. 1995;92: 1084-8.
13. van der Wal AC, Becker AE, van der Loos CM, et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36-44.
14. Frostegard J, Ulfgren AK, Nyberg Pet al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis. 1999;145:33-43.
15. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995;92:657-71.
16. Davies MJ, Thomas AC. Plaque fissuring-the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J. 1985;53:363-73.
17. Fuster V. Elucidation of the role of plaque instability and rupture in acute coronary events. Am J Cardiol. 1995;76: 24C-33C.
18. Burke AP, Farb A, Malcom GT, et al. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med. 1997;336:1276-82.
19. Farb A, Burke AP, Tang AL, et al. Coronar plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation. 1996;93:1354-63.
20. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503-16.
21. Volmink JA, Newton JN, Hicks NR, et al., The Oxford Myocar-dial Infarction Incidence Study Group. Coronary event and case fatality rates in an English population: results of the Oxford myocardial infarction incidence study. Heart. 1998;80:40-4.
22. Ahmar W, Lefkovits J, Acute ST. elevation myocardial infarction with angiographically normal coronary arteries: causes and outcomes. Int J Cardiol. 2008;128:131-3.
23. DeWood MA, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 1980;303:897-902.
24. DeWood MA, Stifter WF, Simpson CS, et al. Coronary arterio-graphic findings soon after non-Q-wave myocardial infarction. N Engl J Med. 1986;315:417-23.
25. Ambrose JA, Tannenbaum MA, Alexopoulos D, et al. Angi-ographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol. 1988;12:56-62.
26. Schoenhagen P, Ziada KM, Kapadia SR, et al. Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: an intravascular ultrasound study. Circulation. 2000;101:598-603.
27. Hong MK, Mintz GS, Lee CW, et al. Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: a three-vessel intravascular ultrasound study in 235 patients. Circulation. 2004;110:928-33.
28. Lee SY, Mintz GS, Kim SY, et al. Attenuated plaque detected by intravascular ultrasound: clinical, angiographic, and morphologic features and post-percutaneous coronary intervention complications in patients with acute coronary syndromes. J Am Coll Cardiol Intv. 2009;2:65-72.
29. HaraH,TsunodaT, MoroiM, etal. Ultrasound attenuation behind coronary atheroma without calcification: mechanism revealed by autopsy. Acute Card Care. 2006;8:110-2.
30. Wu X, Mintz GS, Xu K, et al. The relationship between attenuated plaque identified by intravascular ultrasound and no-reflow after stenting in acute myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. J Am Coll Cardiol Intv. 2011;4:495-502.
31. Bayturan O, Tuzcu EM, Nicholls SJ, et al. Attenuated plaque at nonculprit lesions in patients enrolled in intravascular ultrasound atherosclerosis progression trials. J Am Coll Cardiol Intv. 2009;2:672-8.
32. Nair A, Margolis MP, Kuban BD, et al. Automated coronaryplaque characterisation with intravascular ultrasound backscatter: ex vivo validation. EuroIntervention. 2007;3:113-20.
33. Stone GW, Maehara A, Lansky AJ, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364:226-35.
34. Yabushita H, Bouma BE, Houser SL, et al. Characterization of human atherosclerosis by optical coherence tomography. Circulation. 2002;106:1640-5.
35. Kubo T, Imanishi T, Takarada S, et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronaryangioscopy. J Am Coll Cardiol. 2007;50: 933-9.
36. Giattina SD, Courtney BK, Herz PR, et al. Assessment of coronary plaque collagen with polarization sensitive optical coherence tomography (PS-OCT). Int J Cardiol. 2006;107: 400-9.
37. Uchida Y, Nakamura F, Tomaru T, et al. Prediction of acute coronary syndromes by percutaneous coronary angioscopy in patients with stable angina. Am Heart J. 1995;130: 195-203.
38. Ueda Y, Ohtani T, Shimizu M, et al. Assessment ofplaque vulnerability by angioscopic classification of plaque color. Am Heart J. 2004;148:333-5.
39. Wang J, GengYJ, Guo B, etal. Near-infrared spectroscopic characterization of human advanced atherosclerotic plaques. J Am Coll Cardiol. 2002;39:1305-13.
40. Garg S, Serruy PW, van der Ent M, et al. First use in patients of a combined near infra-red spectroscopy and intra-vascular ultrasound catheter to identify composition and structure of coronary plaque. EuroIntervention. 2010;5:755-6. J. Silva Marques, F. J. Pinto
41. Wang B, Karpiouk A, Yeager D, et al. In vivo intravascular ultrasound-guided photoacoustic imaging of lipid in plaques using an animal model of atherosclerosis. Ultrasound Med Biol. 2012;38:2098-103.
42. Larose E, Yeghiazarians Y, Libby P, et al. Characterization of human atherosclerotic plaques by intravascu-lar magnetic resonance imaging. Circulation. 2005;112: 2324-31.
43. Pundziute G, Schuijf JD, Jukema JW, et al. Evaluation of plaque characteristics in acute coronary syndromes: non-invasive assessment with multi-slice computed tomography and invasive evaluation with intravascular ultrasound radiofrequency data analysis. Eur Heart J. 2008;29: 2373-81.
44. Schroeder S, Flohr T, Kopp AF, et al. Accuracy of density measurements within plaques located in artificial coronary arteries by X-ray multislice CT: results of a phantom study. J Comput Assist Tomogr. 2001;25:900-6.
45. Schroeder S, Kuettner A, Leitritz M, et al. Reliability of differentiating human coronary plaque morphology using contrast-enhanced multislice spiral computed tomography: a comparison with histology. J Comput Assist Tomogr. 2004;28: 449-54.
46. Pohle K, Achenbach S, Macneill B, et al. Characterization ofnon-calcified coronary atherosclerotic plaque by multi-detector row CT: comparison to IVUS. Atherosclerosis. 2007;190:174-80.
47. Motoyama S, Kondo T, Sarai M, et al. Multislice computed tomo-graphic characteristics of coronary lesions in acute coronary syndromes. J Am Coll Cardiol. 2007;50:319-26.
48. Motoyama S, Sarai M, Harigaya H, et al. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol. 2009;54:49-57.
49. Kato S, Kitagawa K, Ishida N, et al. Assessment of coronary artery disease using magnetic resonance coronary angiogra-phy: a national multicenter trial. J Am Coll Cardiol. 2010;56: 983-91.
50. Pouleur AC, le Polain de Waroux JB, Kefer J, et al. Direct comparison of whole-heart navigator-gated magnetic resonance coronary angiography and 40-and 64-slice multidetector row computed tomography to detect the coronary artery stenosis in patients scheduled for conventional coronary angiography. Circ Cardiovasc Imaging. 2008;1:114-21.
51. Liu X, Zhao X, Huang J, et al. Comparison of 3D free-breathing coronary MR angiography and 64-MDCT angiography for detection of coronary stenosis in patients with high calcium scores. Am J Roentgenol. 2007;189:1326-32.
52. Fayad ZA, Fuster V, Fallon JT, et al. Noninvasive in vivo human coronary artery lumen and wall imagin using black-blood magnetic resonance imaging. Circulation. 2000;102:506-10.
53. Miao C, Chen S, Macedo R, et al. Positive remodeling of the coronary arteries detected by magnetic resonance imaging in an asymptomatic population: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2009;53:1708-15.
54. Toussaint JF, LaMuraglia GM, Southern JF, et al. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation. 1996;94:932-8.
55. Fuster V, Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation. 1994;90:2126-46.
56. Casscells W, Hathorn B, David M, et al. Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implications for plaque rupture and thrombosis. Lancet. 1996;347:1447-51.
57. Takumi T, Lee S, Hamasaki S, et al. Limitation of angiographyto identify the culprit plaque in acute myocardial infarction with coronary total occlusion utility of coronary plaque temperature measurement to identify the culprit plaque. J Am Coll Cardiol. 2007;50:2197-203.
58. Tearney GJ, Yabushita H, Houser SL, et al. Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation. 2003;107: 113-9.
59. MacNeill BD, Jang IK, Bouma BE, et al. Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease. J Am Coll Cardiol. 2004;44:972-9.
60. Uchida Y, Nakamura F, Morita T. Observation of atherosclerotic lesions by an intravascular microscope in patients with arteriosclerosis obliterans. Am Heart J. 1995;130: 1114-9.
61. Razansky RN, Rosenthal A, Mallas G, et al. Near-infrared fluorescence catheter system for two-dimensional intravascular imaging in vivo. Opt Express. 2010;18:11372-81.
62. Jaffer FA, Vinegoni C, John MC, et al. Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis. Circulation. 2008;118:1802-9.
63. Nahrendorf M, Zhang H, Hembrador S, et al. Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation. 2008;117:379-87.
64. Nahrendorf M, Jaffer FA, Kelly KA, et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation. 2006;114:1504-11.
65. Jaffer FA, Tung CH, Wykrzykowska JJ, et al. Molecular imaging of factor XIIIa activity in thrombosis using a novel, near-infrared fluorescent contrast agent that covalently links to thrombi. Circulation. 2004;110:170-6.
66. Yeager D, Karpiouk A, Wang B, et al. Intravascular photoacoustic imaging of exogenously labeled atherosclerotic plaque through luminal blood. J Biomed Opt. 2012;17:106016.
67. Razansky D, Harlaar NJ, Hillebrands JL, et al. Multispectral optoacoustic tomography of matrix metalloproteinase activity in vulnerable human carotid plaques. Mol Imaging Biol. 2012;14:277-85.
68. Hamilton AJ, Huang SL, Warnick D, et al. Intravascular ultrasound molecular imagin of atheroma components in vivo. J Am Coll Cardiol. 2004;43:453-60.
69. Hara M, Goodman PC, Leder RA. FDG-PET finding in early-phase Takayasu arteritis. J Comput Assist Tomogr. 1999;23: 16-8.
70. Tawakol A, Migrino RQ, Bashian GG, et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol. 2006;48:1818-24.
71. Rogers IS, Nasir K, Figueroa AL, et al. Feasibility of FDG Imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina. J Am Coll Cardiol Img. 2010;3:388-97.
72. Nahrendorf M, Keliher E, Panizzi P,et al. 18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis. J Am Coll Car-diol Img. 2009;2:1213-22.
73. Izquierdo-Garcia D, Davies JR, Graves MJ, et al. Comparison of methods for magnetic resonance-guided [18-F]fluorodeoxyglucose positron emission tomography in human carotid arteries: reproducibility, partial volume correction, and correlation between methods. Stroke. 2009;40: 86-93.
74. Rudd JH, Myers KS, Bansilal S, et al. Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med. 2008;49:871-8.
75. Rudd JH, Myers KS, Bansilal S, et al. (18)Fluorodeoxyglu-cose positron emission tomography imagin of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol. 2007;50:892-6.
76. Zhang J, Nie L, Razavian M, et al. Molecular imaging ofactivated matrix metalloproteinases in vascular remodeling. Circulation. 2008;118:1953-60.
77. Kietselaer BL, Reutelingsperger CP, Heidendal GA, et al. Nonin-vasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. N Engl J Med. 2004;350:1472-3.
78. Sakuma T, Sklenar J, Leong-Poi H, et al. Molecular imaging identifies regions with microthromboemboli during primary angioplasty in acute coronary thrombosis. J Nucl Med. 2004;45:1194-200.
79. Leuschner F, Nahrendorf M. Molecular imaging of coronary atherosclerosis and myocardial infarction: considerations for the bench and perspectives for the clinic. Circ Res. 2011;108:593-606.
80. Trivedi RA, Mallawarachi C, King-Im JM, et al. Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. Arterioscler Thromb Vasc Biol. 2006;26:1601-6.
81. Tang T, Howarth SP, Miller SR, et al. Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI. Stroke. 2006;37:2266-70.
82. Nahrendorf M, Sosnovik D, Chen JW, et al. Activatable magnetic resonance imaging agent reports myeloperoxidase activity in healing infarcts and noninvasively detects the antiinflammatory effects of atorvastatin on ischemia-reperfusion injury. Circulation. 2008;117:1153-60.
83. Sosnovik DE, Garanger E, Aikawa E, et al. Molecular MRI of car-diomyocyte apoptosis with simultaneous delayed-enhancement MRI distinguishes apoptotic and necrotic myocytes in vivo: potential for midmyocardial salvage in acute ischemia. Circ Cardiovasc Imaging. 2009;2:460-7.
84. Winter PM, Morawski AM, Caruthers SD, et al. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. Circulation. 2003;108:2270-4.
85. Spuentrup E, Katoh M, Wiethoff AJ, et al. Molecular coronary MR imaging of human thrombi using EP-2104R, a fibrin-targeted contrast agent: experimental study in a swine model. Rofo. 2007;179:1166-73.
86. Vymazal J, Spuentrup E, Cardenas-Molina G, et al. Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility. Invest Radiol. 2009;44:697-704.
87. Hyafil F Cornily JC, Feig JE, et al. Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nat Med. 2007;13:636-41.
88. Davies PF. Flow-mediated endothelial mechanotransduction. Physiol Rev. 1995;75:519-60.
89. Dai G, Kaazempur-Mofrad MR, Natarajan S, et al. Distinct endothelial phenotypes evoked by arterial waveforms derived from atherosclerosis-susceptible and-resistant regions of human vasculature. Proc Natl Acad Sci U S A. 2004;101: 14871-6.
90. Samijo SK, Willigers JM, Brands PJ, et al. Reproducibil-ity of shear rate and shear stress assessment by means of ultrasound in the common carotid artery of young human males and females. Ultrasound Med Biol. 1997;23: 583-90.
91. Lotz J, Meier C, Leppert A, et al. Cardiovascular flow measurement with phase-contrast MR imaging: basic facts and implementation. Radiographics. 2002;22:651-71.
92. Li W, Lancee CT, Cespedes EI, et al. Decorrelation of intravas-cular echo signals: potentials for blood velocity estimation. J Acoust Soc Am. 1997;102:3785-94.
93. Doriot PA, Dorsaz PA, Dorsaz L, et al. In-vivo measurements of wall shear stress in human coronary arteries. Coron Artery Dis. 2000;11:495-502.
94. Fukumoto Y,Hiro T, Fujii T,et al. Localized elevation of shear stress is related to coronary plaque rupture: a 3-dimensional intravascular ultrasound study with in-vivo color mapping of shear stress distribution. J Am Coll Cardiol. 2008;51: 645-50.
95. Stone PH, Saito S, Takahashi S, et al. Prediction of progression of coronary artery disease and clinical outcomes using vascular profiling of endothelial shear stress and arterial plaque charac-teristics: the PREDICTION Study. Circulation. 2012;126:172-81.
96. de Korte CL, van der Steen AF, Cespedes EI, et al. Intravascular ultrasound elastography in human arteries: initial experience in vitro. Ultrasound Med Biol. 1998;24: 401-8.
97. Doyley MM, Mastik F, de Korte CL, et al. Advancing intravascu-lar ultrasonic palpation toward clinical applications. Ultrasound Med Biol. 2001;27:1471-80.
98. Schaar JA, Regar E, Mastik F, et al. Incidence of high-strain patterns in human coronary arteries: assessment with three-dimensional intravascular palpography and correlation with clinical presentation. Circulation. 2004;109: 2716-9